Latest News and Press Releases
Want to stay updated on the latest news?
-
Totaligent (OTCID:TGNT) successfully closed the strategic acqui-hire of the Aetherium Medical platform and team.
-
ADMA Biologics 29% Stock Drop Triggers Securities Fraud Investigation Over Channel Stuffing Claims – Investors Urged to Contact BFA Law
-
After a thorough process, management are pleased to undertake this pivotal step for GMP production of PRP for the upcoming Phase 1 FIH clinical study
-
ADMA Biologics is being Investigated for Securities Fraud after 29% Stock Drop -- Investors Reminded to Contact BFA Law
-
The biologics sector is rapidly emerging as one of the most closely watched growth stories in healthcare $HCWB, $TGNT, $MRNA, $REGN
-
ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law
-
Totaligent (OTCID: TGNT) Targets $273B Medical Tourism Market Via Aetherium Acquisition
-
ADMA Biologics Inquiry Alert: Investors with Losses after Channel Stuffing Allegations are Urged to Contact BFA Law about its Securities Investigation
-
The strategic alliance expands existing collaboration and strengthens OTXL’s ability to advance cell and gene therapies for ultra-rare conditions.
-
ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money